What is CUSIP 00775E102?

CUSIP 00775E102 is the security identifier used in SEC filing datasets for 00775E102 - AEON Biopharma, Inc. - Common Stock, $0.0001 par value per share.

Security Snapshot

AEON Biopharma, Inc. - Common Stock, $0.0001 par value per share Institutional Ownership

Q: Who owns 00775E102 - AEON Biopharma, Inc. - Common Stock, $0.0001 par value per share based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CUSIP: 00775E102

13F Institutional Holders and Ownership History

13F reference period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period

Security type / class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 24,024,279

Filing notes and source

Key facts

00775E102 - AEON Biopharma, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 00775E102.
13F reference-period holder data is not available.
1 significant owner is listed from Schedule 13D/13G reporting.

Change

Holder data for the Q2 2026 reference period is not available.
Available periods remain in the history table; they do not substitute for the headline period.

Research use

You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

00775E102

13F reference period

n/a

13F holders

13D/G owners

CIK / CUSIP context first

00775E102 full holder history AEON Biopharma, Inc. SEC filings AEON Biopharma, Inc. company facts AEON Biopharma, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows

Security

00775E102

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Daewoong Co., Ltd	50%	+4909%			12,009,737	+13046%	Daewoong Co.,Ltd. ("DWC")	21 Jan 2026